17-OCT-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  2 0 0 2 24 2 12
BREAST 924 25 1304 92 1120 177 1077
ERLYTX 93 2 104 7 85 17 103
GI 196 5 261 22 268 37 225
GU 450 7 365 32 390 55 335
LEUK 128 2 104 19 231 33 201
LUNG 288 2 104 9 110 31 189
LYMPH 373 4 209 39 475 69 420
MELAN 357 0 0 0 0 11 67
MMYEL 212 2 104 9 110 23 140
MULT 8 2 104 5 61 5 30
OTHER 35 0 0 3 37 9 55
PREV 5 0 0 0 0 0 0
SXQOL 3 0 0 0 0 0 0
Total 3074 51 2659 239 2911 469 2854

17-OCT-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  2 0 0 2 24 2 12
CCD 192 2 104 8 97 16 97
ERLYTX 10 0 0 0 0 2 12
LEUK 669 10 522 55 670 111 676
LUNG 277 8 417 41 499 76 463
LYMPH 1 0 0 0 0 1 6
OTHER 30 1 52 2 24 9 55
PEOLC 96 6 313 19 231 34 207
PREV 269 4 209 16 195 39 237
SURV 13 2 104 3 37 5 30
SXQOL 591 5 261 42 511 88 536
Total 2150 38 1982 188 2288 383 2331

17-OCT-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  4 0 0 4 49 4 24
BREAST 924 25 1304 92 1120 177 1077
CCD 192 2 104 8 97 16 97
ERLYTX 103 2 104 7 85 19 116
GI 196 5 261 22 268 37 225
GU 450 7 365 32 390 55 335
LEUK 797 12 626 74 901 144 877
LUNG 565 10 522 50 609 107 651
LYMPH 374 4 209 39 475 70 426
MELAN 357 0 0 0 0 11 67
MMYEL 212 2 104 9 110 23 140
MULT 8 2 104 5 61 5 30
OTHER 65 1 52 5 61 18 110
PEOLC 96 6 313 19 231 34 207
PREV 274 4 209 16 195 39 237
SURV 13 2 104 3 37 5 30
SXQOL 594 5 261 42 511 88 536
Total 5224 89 4642 427 5200 852 5185

17-OCT-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  2 0 0 2 24 2 12
BREAST 567 17 887 58 706 107 651
ERLYTX 51 2 104 5 61 10 61
GI 148 4 209 14 170 28 170
GU 385 6 313 26 317 43 262
LEUK 79 0 0 7 85 16 97
LUNG 180 2 104 5 61 20 122
LYMPH 241 1 52 25 304 42 256
MELAN 225 0 0 0 0 7 43
MMYEL 131 1 52 6 73 14 85
MULT 4 1 52 2 24 2 12
OTHER 35 0 0 3 37 9 55
PREV 5 0 0 0 0 0 0
SXQOL 3 0 0 0 0 0 0
Total 2056 34 1773 153 1862 300 1826

17-OCT-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  2 0 0 2 24 2 12
CCD 160 1 52 5 61 11 67
ERLYTX 10 0 0 0 0 2 12
LEUK 305 6 313 23 280 47 286
LUNG 165 6 313 26 317 48 292
LYMPH 1 0 0 0 0 1 6
OTHER 30 1 52 2 24 9 55
PEOLC 65 4 209 14 170 25 152
PREV 267 2 104 14 170 37 225
SURV 13 2 104 3 37 5 30
SXQOL 405 3 157 30 365 65 396
Total 1423 25 1304 119 1448 252 1533

17-OCT-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  4 0 0 4 49 4 24
BREAST 746 20 1044 76 925 136 828
CCD 190 3 157 12 146 18 110
ERLYTX 61 2 104 5 61 12 73
GI 152 4 209 12 146 27 164
GU 402 7 365 27 329 51 310
LEUK 384 6 313 30 365 63 384
LUNG 346 8 417 31 377 68 414
LYMPH 242 1 52 25 304 43 262
MELAN 225 0 0 0 0 7 43
MMYEL 130 1 52 6 73 14 85
MULT 15 0 0 6 73 9 55
OTHER 227 1 52 16 195 40 244
PEOLC 73 4 209 15 183 22 134
PREV 272 2 104 14 170 37 225
SURV 13 2 104 3 37 5 30
SXQOL 408 3 157 30 365 65 396
Total 3890 64 3339 312 3798 621 3781

17-OCT-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 797 22 1148 75 913 151 919
ERLYTX 89 1 52 5 61 15 91
GI 103 3 157 13 158 22 134
GU 235 3 157 19 231 34 207
LEUK 98 2 104 17 207 28 170
LUNG 259 2 104 9 110 27 164
LYMPH 303 4 209 34 414 60 365
MMYEL 199 2 104 8 97 21 128
MULT 8 2 104 5 61 5 30
Total 2091 41 2139 185 2252 363 2208

17-OCT-2025 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1987 40 2087 163 1985 323 1966
AFFIL 157 2 104 15 183 29 177
CCOP/NCORP 1335 17 887 94 1144 200 1218
Non-SWOG 1740 25 1304 150 1826 295 1796
Total 5219 84 4382 422 5138 847 5157

17-OCT-2025 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK MM1OA-S03 AML, Newly Dx, Ven+ASTX727 vs Ven+ASTX727+Ena 1 T 08-OCT-25
LEUK S1905 T-ALL/T-LBL, Rel/Ref, OBI-3424 1 T 02-OCT-25

17-OCT-2025 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 17
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 10
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 9
LUNG LUNGMAP NSCLC, Adv, Master 1 8
LUNG LUNGMAP NSCLC, Adv, Master 2 6
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 5
PEOLC S1501 Surv, Breast Stg IV, Card Tox w/ Carvedilol 2 3
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 3
GI S2303 Gas/Esoph/GEJ, Adv, Ram + Pac +/- Nivo 1 3
PEOLC S2408 Panc Fistula Prevention, Lanreotide 1 3